Table 4.

Clinical features and biochemical parameters at baseline and week 12.

Variations	Placebo	M	PM	p	Placebo	M	PM	p
	Baseline				Week 12
BMI (kg/m2)	24.00 ± 4.82	23.54 ± 3.34	24.00 ± 4.10	0.898	23.88 ± 3.95	21.90 ± 3.05	22.48 ± 3.16	0.13
LH (IU/L)	9.72 ± 2.23	9.61 ± 3.74	9.53 ± 3.31	0.992	9.82 ± 1.80	7.20 ± 1.80	6.33 ± 1.98	0.087
FSH (IU/L)	6.28 ± 2.10	6.31 ± 1.52	6.17 ± 1.70	0.962	6.26 ± 1.56	6.46 ± 1.37	5.32 ± 1.03	0.447
PRL (μg/L)	13.54 ± 2.17	13.69 ± 2.27	13.51 ± 2.97	0.995	13.16 ± 2.80	13.69 ± 2.82	14.50 ± 2.57	0.448
TT (μg/L)	0.77 ± 0.22	0.82 ± 0.22	0.77 ± 0.23	0.876	0.67 ± 0.24	0.60 ± 0.19	0.48 ± 0.13∗	<0.001
HOMA-IR	3.21 ± 1.30	3.41 ± 0.65	3.20 ± 0.53	0.861	3.28 ± 1.42	3.06 ± 0.83	2.24 ± 0.74	0.076

^∗Group PM vs. group M at 12 w; p = 0.024.